IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?

IDEAL DOSE OF ACETYLSALICYLIC ACID FOR CARDIAC PATIENTS: THE SEARCH IS OVER?

.

Saved in:

Bibliographic Details
Main Author:	O. V. Averkov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1134
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01)

Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01)

THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS
by: O. D. Ostroumova, et al.
Published: (2018-07-01)

Finding the right dose of acetylsalicylic acid for secondary prevention of atherosclerotic cardiovascular disease
by: André Garcia, et al.
Published: (2025-07-01)

COMBINED ACETYLSALICYLIC ACID TABLETS TECHNOLOGY
by: A. V. Simonyan, et al.
Published: (2019-01-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

ACETYLSALICYLIC ACID IN RHEUMATOLOGY: NEW EVIDENCE
by: Yuri Vladimirovich Muravyev, et al.
Published: (2013-12-01)

Acetylsalicylic acid in primary prevention among patients with arterial hypertension
by: A. V. Melekhov, et al.
Published: (2013-10-01)

ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS
by: V. V. Rafalsky, et al.
Published: (2017-08-01)

Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01)

ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE
by: P. S. Laguta
Published: (2017-05-01)

Postgenomic aspects of resistance to acetylsalicylic acid in patients with coronary artery disease
by: Yu. I. Grinshtein, et al.
Published: (2024-11-01)

Agronomic Responses of Forages to the Effect of Acetylsalicylic Acid
by: Santiago Alexander Guamán-Rivera, et al.
Published: (2025-04-01)

Effects of ozone and GAC on the removal of acetylsalicylic acid
by: Oussama Khemis, et al.
Published: (2025-01-01)

Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01)

Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01)

CREATING A PROLONGED FORM OF ACETYLSALICYLIC ACID: AN EXPERIMENTAL APPROACH
by: V. I. Sevastianov, et al.
Published: (2016-04-01)

Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects
by: L. M. Krasnykh, et al.
Published: (2021-12-01)

ASSAY OF ACETYLSALICYLIC ACID IN DRUG PRODUCTS BY DIFFERENTIAL SCANNING CALORIMETRY
by: A. M. Stoinova, et al.
Published: (2019-01-01)

Current approaches to the selection of acetylsalicylic acid dosage forms in cardiology
by: S. R. Gilyarevskiy, et al.
Published: (2022-06-01)

ACETYLSALICYLIC ACID IN CARDIOLOGY: BENEFITS, RISKS, AND CLINICAL INDICATIONS
by: Ciprian Adrian Dinu, et al.
Published: (2025-03-01)

Thermodynamic and Calorimetric Study of Acetylsalicylic Acid (Aspirin) and Ibuprofen
by: Juan Carlos Moreno-Piraján, et al.
Published: (2011-01-01)

Study of Acetylsalicylic Acid Adsorption Using Molecular Sieves
by: G.A. Assumpção, et al.
Published: (2015-02-01)

Antithrombotic effect of different acetylsalicylic acid drug formulations: is there a difference?
by: A. V. Sidorov
Published: (2021-11-01)

Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-03-01)

LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
by: I. V. Zhirov
Published: (2016-01-01)

Myocardial Infarction, Peptic Ulcer and Acetylsalicylic Acid: Of Good and Evil
by: John K Marshall
Published: (2009-01-01)

GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY
by: A. L. Komarov
Published: (2016-01-01)

Effect of Silica Surface on Hydrolysis of Acetylsalicylic Acid: Theoretical Simulation
by: E. M. Demianenko
Published: (2011-11-01)

Adsorption of Paracetamol and Acetylsalicylic Acid onto Commercial Activated Carbons
by: Sabina Beninati, et al.
Published: (2008-11-01)

Use of acetylsalicylic acid and agronomic performance of potatoes in Lima region
by: Sergio Contreras-Liza, et al.
Published: (2022-04-01)

RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY
by: . Editorial
Published: (2017-05-01)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

ENGLISH VERSION: PERSONALIZED DESENSITIZATION WITH ACETYLSALICYLIC ACID IN PATIENTS WITH HYPERSENSITIVITY TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: A.V. Lavrenko, et al.
Published: (2020-04-01)